Accuray Wins Japanese Approval for Expanded Use of CyberKnife System
Accuray has announced that Japan’s Ministry of Health, Labor and Welfare has granted Shonin approval of the CyberKnife robotic radiosurgery system for use in treatment of extracranial tumors, including tumors that move with respiration.
This regulatory approval expands the types of patients that can be treated with radiosurgery. As a result of this approval, the CyberKnife system may be used in Japan to treat tumors anywhere in the body, including those in the spine, lung, liver, pancreas and prostate, the company said.
Accuray will work with its existing distributor to sell the CyberKnife system and increase patient access to its benefits. The CyberKnife system offers cancer patients worldwide a pain-free, non-invasive alternative to surgery, said Accuray.